Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-25-015001
Filing Date
2025-02-19
Accepted
2025-02-19 06:06:16
Documents
6

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0200357-15.htm 424B4 4240673
2 GRAPHIC tanbio_logo.jpg GRAPHIC 36147
3 GRAPHIC tflowchart_001.jpg GRAPHIC 344373
4 GRAPHIC timage_005.jpg GRAPHIC 411207
5 GRAPHIC timage_006.jpg GRAPHIC 626201
6 GRAPHIC tycm_logo.jpg GRAPHIC 37162
  Complete submission text file 0001213900-25-015001.txt   6246562
Mailing Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308
Business Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 4916096247281
Anbio Biotechnology (Filer) CIK: 0001982708 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-284106 | Film No.: 25637084
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)